Cargando…
Pustular Psoriasis in a Patient Treated with Dupilumab for Atopic Dermatitis: A Case Report
Psoriasis and atopic dermatitis are relatively common in clinical practice, but it is rare for the two diseases to co-occur in the same patient. Dupilumab, an anti-IL-4/IL-13 monoclonal antibody, has been approved for treating moderate to severe AD. In addition to its therapeutic effects, dupilumab...
Autores principales: | Liu, Li, Chen, Jie, Tang, Kangheng, Li, Feng, Li, Si, Ding, Xiaojie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437099/ https://www.ncbi.nlm.nih.gov/pubmed/37601418 http://dx.doi.org/10.2147/CCID.S420904 |
Ejemplares similares
-
Psoriasis appearing after dupilumab therapy in atopic dermatitis: A case report
por: Kim, Ho Seung, et al.
Publicado: (2020) -
Alopecia areata-like and psoriasis after dupilumab use for atopic dermatitis()()
por: Maiolini, Viviane Maria, et al.
Publicado: (2021) -
Dupilumab-induced phenotype switching from atopic dermatitis to psoriasis
por: Varma, Aakaash, et al.
Publicado: (2020) -
Dupilumab for atopic dermatitis
Publicado: (2019) -
Conjunctivitis in patients with atopic dermatitis treated with dupilumab
por: Ferreira, Sandra, et al.
Publicado: (2020)